Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Preliminary results
Director departure
Quarterly results
CC transcript
ANGIODYNAMICS INC (ANGO) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/04/2023 8-K Quarterly results
Docs: "AngioDynamics Reports Fiscal Year 2024 First Quarter Financial Results; Reaffirms Fiscal Year 2024 Guidance",
"Presentation"
07/24/2023 8-K Quarterly results
07/12/2023 8-K Quarterly results
06/08/2023 8-K Asset disposition
Docs: "Latham, New York, June 8, 2023 – AngioDynamics, Inc. , a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving quality of life for patients, today announced that it has completed the sale of its Dialysis product portfolio and BioSentry Tract Sealant System Biopsy product to Merit Medical Systems, Inc. for $100 million in cash. The transaction consists of AngioDynamics’ DuraFlow™, DuraMax ® , Evenmore ® , Schon XL ® , Trio-CT ® and Vaxel Plus Hemodialysis Catheter brands, and BioSentry™ Tract Sealant System Biopsy brand. This combined portfolio of products contributed approximately $32 million in sales in AngioDynamics’ Fiscal Year 2023. AngioDynamics intends t..."
06/02/2023 8-K Other Events  Interactive Data
04/17/2023 8-K Quarterly results
03/30/2023 8-K Quarterly results
03/06/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Presentation slides for the Raymond James 44th Annual Institutional Investors Conference"
02/27/2023 8-K Other Events  Interactive Data
01/12/2023 8-K Quarterly results
01/05/2023 8-K Quarterly results
11/30/2022 8-K Quarterly results
11/23/2022 8-K Quarterly results
11/04/2022 8-K Quarterly results
10/06/2022 8-K Quarterly results
10/06/2022 8-K Quarterly results
08/31/2022 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Ob...
Docs: "Credit Agreement, by and among AngioDynamics, Inc., the lenders party thereto, JPMorgan Chase Bank, N.A., as administrative agent, Bank of America, N.A. and KeyBank National Association as co-syndication agents and JPMorgan Chase Bank N.A., as sole bookrunner and sole lead arranger"
08/10/2022 8-K Quarterly results
07/12/2022 8-K Quarterly results
04/07/2022 8-K Quarterly results
Docs: "AngioDynamics Reports Fiscal 2022 Third Quarter Financial Results; Reaffirms Fiscal Year 2022 Guidance",
"Presentation"
01/10/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Presentation slides for the 24th Annual Needham Virtual Growth Conference"
01/06/2022 8-K Quarterly results
Docs: "AngioDynamics Reports Fiscal 2022 Second Quarter Financial Results; Reaffirms Revenue Guidance; Revises Gross Margin and Adjusted EPS Guidance",
"Presentation"
12/06/2021 8-K Quarterly results
11/03/2021 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
09/30/2021 8-K Quarterly results
07/13/2021 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Presentation slides for the AngioDynamics Investor & Technology Day"
07/13/2021 8-K Quarterly results
Docs: "AngioDynamics Reports Fiscal 2021 Fourth Quarter and Full-Year Financial Results",
"Presentation"
05/25/2021 8-K Quarterly results
04/12/2021 8-K Quarterly results
03/30/2021 8-K Quarterly results
03/09/2021 8-K Quarterly results
02/03/2021 8-K Quarterly results
01/11/2021 8-K Quarterly results
01/07/2021 8-K/A Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy